Stanford University
Showing 5,101-5,150 of 34,952 Results
-
Edward C. Cheng
Affiliate, FSI
BioDr. Edward C. Cheng is a technology strategist and visionary leader. He serves as Senior Advisor for the cross-industry Safe AI Agents Consortium Group, whose members include Anthropic, Cohere, Meta, Microsoft, Oracle, PayPal, DoorDash, PwC, Inquiryon, and others. He is also the Chief Technology Officer and Executive Chairman of Inquiryon. Previously, Edward served as VP of AI at Oracle NetSuite and held senior leadership roles at HP.
Edward is the lead inventor of the Log-Structured Merge Tree (LSM Tree), a foundational data structure that enables low-latency, high-throughput, and high-velocity data processing. It is widely adopted by major data management systems across industry, including Google, Meta, X, Microsoft, Oracle, Hadoop, Cassandra, MongoDB, RocksDB, and many others.
His work on Safe AI Agents focuses on governance frameworks, human-centric AI principles, and multi-agent systems that align autonomous AI with democratic values and human oversight. He collaborates across academia, industry, and civil society to advance research, publish scholarly work, and help shape emerging best practices for safe and trustworthy AI agent development and deployment. He also speaks globally about the impacts and risks of AI agents and AGI with diverse communities.
Edward writes under the pen name Edward Sizhe on topics spanning faith, technology, and life purpose. His books include "AI and God," "Journey of Life or Death," and "Five Questions Toward Enriching the Meaning and Purpose of Life, available on Kindle and Amazon."
His research interests include AI agents, distributed big data systems, machine learning and deep learning, parallel search algorithms, high-performance computing, and distributed systems. He is also interested in biblical studies and archaeological evidence surrounding biblical events. Edward has published numerous scientific papers and holds multiple patents in AI, machine learning, and database systems. He previously worked with the Stanford Database Research Group and now serves as Senior Advisor and researcher at the Stanford Deliberative Democracy Lab.
Edward received his PhD in Computer Science from the University of London, his master’s degree from UC Berkeley, and an MBA from Columbia University. -
Evaline Cheng, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsCardio-oncology
Cardiotoxicity
Delivery of care
Health care systems -
Hannah Cheng
Soc Science Rsch Prof 3, Psych/Public Mental Health & Population Sciences
BioHannah Cheng, MS is a Research Scientist at the Stanford Center for Dissemination and Implementation. Her overarching goal is to leverage implementation science to dismantle systemic barriers and improve access to behavioral health services. Her work focuses on identifying strategies to implement innovations in resource-limited settings and integrating economic evaluations in implementation research to maximize return on investment
-
Jordan C. Cheng, DMD, PhD
Postdoctoral Scholar, Stanford Cancer Institute
Current Research and Scholarly InterestsMy research direction involves the evalutation of single-stranded library prepartion methods versus conventional double-stranded methods of cell-free DNA for non-invasive cancer profiling applications. The exploration of these technologies allow for the inference of the genomic and epigenetic features of both local and distant cell types associated with a biofluid.
-
Paul Cheng MD PhD
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Cheng is a Cardiologist at Stanford University School of Medicine in the Department of Medicine and a member of the Cardiovascular Research Institute. Dr. Cheng received his BEng in Chemical Engineering and BSc in biology at MIT. He subsequently completed his MD/PhD at UCSF working in the Srivastava lab studying how extracellular morphogenic signals affect cardiac development and fate determination of cardiac progenitors. Dr. Cheng completed internal medicine residency and cardiology fellowship at Stanford, including a post-doctoral training in the Quertermous lab. His current clinical focus is in amyloidosis and cardio-oncology.
Dr. Cheng pioneered the application of single cell transcriptomic and epigenetic techniques to study human vascular diseases including atherosclerosis and aneurysm, and applied these techniques to investigate molecular mechanisms behind genetic risk factors for several human vascular diseases including atherosclerosis, and aortopathies such as Marfan's and Loey-Dietz syndrome. The Cheng lab takes a patient-to-bench-to-bedside approach to science. The lab focuses on elucidating new pathogenic mechanisms of human vascular diseases through combing human genetics and primary vascular disease tissues, with high-resolution transcriptomic and epigenetic profiling to generate novel hypothesis that are then tested in a variety of in vitro and in vivo models. The lab is focused on two broad questions: (1) understanding the biological underpinning of the differences in diseases propensities of different arterial segments in an individual (i.e. why do you have atherosclerosis and aneurysms in certain segments but not others), and (2) understanding the role of perivascular fibroblast in human vascular diseases.
Find out more about what the Cheng lab is up to, check out https://chenglab.stanford.edu -
Tiffany Cheng
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioI am a physician leader and anesthesiologist at Stanford Health Care, where I serve as Medical Director of Perioperative Services at SHC Palo Alto and hold a faculty appointment as Clinical Assistant Professor at Stanford University School of Medicine.
My work sits at the intersection of direct patient care and systems-level leadership. I have a track record of building high-performing clinical teams, designing governance structures from the ground up, and delivering measurable operational impact — including significant improvements in OR utilization, block efficiency, and access to care across Stanford's interventional platform.
I founded Stanford's Anesthesiology Mentorship Program (AMP), a faculty development initiative that received the Augustus A. White III Award, and co-founded ASPIRE, a multi-institutional speaker exchange network. I am a graduate of Stanford's Physician Leadership Certificate Program and will begin an Executive MBA at Santa Clara University in Fall 2026.
I believe that the strongest clinical institutions are built on trust, accountability, and a genuine investment in the people doing the work — and I bring that conviction to every leadership role I hold. -
Xingxing Shelley Cheng
Assistant Professor of Medicine (Nephrology) and, by courtesy, of Surgery (Abdominal Transplantation) and of Health Policy
Current Research and Scholarly InterestsDr. Xingxing Cheng's expertise is in applying the tools of decision science to clinical practice and policy analysis. Her current research is in the following areas:
1) the costs, effectiveness, and implementation of work-up before kidney transplantation, including pretransplant cardiovascular screening;
2) ethics of and decision-making in in multi-organ transplantation. -
Mathieu Chenier
MD Student with Scholarly Concentration in Bioengineering / Cardiovascular-Pulmonary Sciences, expected graduation Spring 2029
Bio• Current MD/PSTP student
• Studied biomedical engineering and engineering physics at McMaster University in Hamilton, Ontario, between 2019-2024
• Interested in pediatric medicine, bioengineering, and engineering in medicine
• From Belle River, Ontario -
David Cheriton
Professor of Computer Science, Emeritus
BioCheriton's research includes the areas of high-performance distributed systems, and high-speed computer communication with a particular interest in protocol design. He leads the Distributed Systems Group in the TRIAD project, focused on understanding and solving problems with the Internet architecture. He has also been teaching and writing about object-oriented programming, building on his experience with OOP in systems building.
-
Annie Bertha Chao
Clinical Assistant Professor (Affiliated), Medicine - Primary Care and Population Health
Staff, Medicine - Primary Care and Population HealthBioDr. Annie Chern grew up in Wichita, Kansas, and remains a Midwestern girl at heart. After attending Washington University in St. Louis for her undergraduate degree, she received her M.D. from Stanford University School of Medicine. She has a special interest in helping patients of all ages with weight management, obesity prevention, and chronic disease care.
Dr. Chern has volunteered her time as a physician at Arbor and Pacific Free Clinics, the two Stanford-associated free clinics that provide basic healthcare for underserved patients. In her leisure time, she enjoys running in all forms - most of all - chasing after her fleet-footed twin toddlers! -
Kateryna Chernohorenko
Affiliate, FSI
BioKateryna Chernohorenko is the architect of Ukraine’s digital transformation and the former Deputy Minister of Defense of Ukraine (2023-2025).
During her government tenure, Kateryna Chernohorenko spearheaded systemic reforms that fortified Ukraine’s institutions and redefined modern warfare:
• Launched Reserve+, a mobile app for conscripts and reservists that digitised military records and integrated recruitment functionality (6M+ users);
• Launched Army+, a dedicated mobile app for active military personnel featuring e-reports, training courses, surveys, discount programs, and cross-unit transfer functionality (1M+ users);
• Scaled DELTA, a Ukrainian battlefield management system — officially certified according to the NATO standards and used by 90% of the Armed Forces’ units;
• Formed and led the Drone and IT coalitions, mobilising over $3.3 billion in military aid.
• Established the Cyber Incident Response Center, securing 24/7 monitoring of Ukrainian cyberspace, preventing data breaches, and ensuring the country’s digital resilience.
• Initiated the creation of the Space Policy Directorate within the Ministry of Defense, laying the legal and institutional foundation for global space security integration.
Currently, Kateryna Chernohorenko serves as a strategic advisor to the global and Ukrainian defense tech industry, providing guidance on digital development and drone warfare. She also shares her expertise as a Senior Lecturer at the National University of Kyiv-Mohyla Academy, teaching the course “E-Governance, Document Management, and Digital Democracy”, and authors a “Chief Strategic Officer in Defence” aimed at C-level managers in the defense industry. -
Athena Cherry
Member, Stanford Cancer Institute
Current Research and Scholarly InterestsThe use of molecular and molecular cytogenetic methods to identify chromosomal abnormalities in acquired and congenital disorders.
-
Mike Cherry
Professor (Research) of Genetics, Emeritus
Current Research and Scholarly InterestsMy research involves identifying, validating and integrating scientific facts into encyclopedic databases essential for research and scientific education. Published results of scientific experimentation are a foundation of our understanding of the natural world and provide motivation for new experiments. The combination of in-depth understanding reported in the literature with computational analyses is an essential ingredient of modern biological research.
